Correlation Between Sarepta Therapeutics and Edgewise Therapeutics
Can any of the company-specific risk be diversified away by investing in both Sarepta Therapeutics and Edgewise Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Sarepta Therapeutics and Edgewise Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Sarepta Therapeutics and Edgewise Therapeutics, you can compare the effects of market volatilities on Sarepta Therapeutics and Edgewise Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Sarepta Therapeutics with a short position of Edgewise Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Sarepta Therapeutics and Edgewise Therapeutics.
Diversification Opportunities for Sarepta Therapeutics and Edgewise Therapeutics
0.6 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Sarepta and Edgewise is 0.6. Overlapping area represents the amount of risk that can be diversified away by holding Sarepta Therapeutics and Edgewise Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Edgewise Therapeutics and Sarepta Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Sarepta Therapeutics are associated (or correlated) with Edgewise Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Edgewise Therapeutics has no effect on the direction of Sarepta Therapeutics i.e., Sarepta Therapeutics and Edgewise Therapeutics go up and down completely randomly.
Pair Corralation between Sarepta Therapeutics and Edgewise Therapeutics
Given the investment horizon of 90 days Sarepta Therapeutics is expected to under-perform the Edgewise Therapeutics. But the stock apears to be less risky and, when comparing its historical volatility, Sarepta Therapeutics is 2.1 times less risky than Edgewise Therapeutics. The stock trades about -0.18 of its potential returns per unit of risk. The Edgewise Therapeutics is currently generating about -0.07 of returns per unit of risk over similar time horizon. If you would invest 3,206 in Edgewise Therapeutics on December 4, 2024 and sell it today you would lose (653.00) from holding Edgewise Therapeutics or give up 20.37% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Significant |
Accuracy | 100.0% |
Values | Daily Returns |
Sarepta Therapeutics vs. Edgewise Therapeutics
Performance |
Timeline |
Sarepta Therapeutics |
Edgewise Therapeutics |
Sarepta Therapeutics and Edgewise Therapeutics Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Sarepta Therapeutics and Edgewise Therapeutics
The main advantage of trading using opposite Sarepta Therapeutics and Edgewise Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Sarepta Therapeutics position performs unexpectedly, Edgewise Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Edgewise Therapeutics will offset losses from the drop in Edgewise Therapeutics' long position.Sarepta Therapeutics vs. Krystal Biotech | Sarepta Therapeutics vs. PTC Therapeutics | Sarepta Therapeutics vs. Iovance Biotherapeutics | Sarepta Therapeutics vs. Madrigal Pharmaceuticals |
Edgewise Therapeutics vs. Century Therapeutics | Edgewise Therapeutics vs. C4 Therapeutics | Edgewise Therapeutics vs. Mineralys Therapeutics, Common | Edgewise Therapeutics vs. Cullinan Oncology LLC |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Funds Screener module to find actively-traded funds from around the world traded on over 30 global exchanges.
Other Complementary Tools
Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins |